Prof Heinz Zwierina, chair of ITOC 2014, talks to ecancertv about the meeting's key points and future.
Immunotherapy for cancer has taken huge leaps forwards in the last couple of years, and progress is only accelerating, so ITOC is set to become an important fixture.